A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...

“We’re proud to partner with CDL Cancer to help accelerate bold ideas that have the power to transform cancer care,” said Wendy Beauchesne, CEO of the Alberta Cancer Foundation. “Together, we’re ...

Middle school students in Laredo designed capes with motivational messages for children with cancer, promoting empowerment ...

A new study has unveiled when chronic myeloid leukaemia, a type of cancer that affects the blood and bone marrow, arises in ...